clinical trials

Vyvgart shines in CIDP study, teeing up another potential nod for Argenx's pipeline in a product
Vyvgart shines in CIDP study, teeing up another potential nod for Argenx's pipeline in a product
Fierce Pharma
Argenx
Vyvgart
clinical trials
CIDP
Flag link:
Lilly shares full pivotal data on Alzheimer’s drug, revealing how it shapes up against Leqembi
Lilly shares full pivotal data on Alzheimer’s drug, revealing how it shapes up against Leqembi
Fierce Biotech
Eli Lilly
Alzheimer's disease
clinical trials
FDA
donanemab
Flag link:
Alnylam and Regeneron report updated positive Phase I results of Alzheimer’s drug
Alnylam and Regeneron report updated positive Phase I results of Alzheimer’s drug
Clinical Trials Arena
Alnylam
clinical trials
ALN-APP
Alzheimer's disease
Flag link:
CEL-SCI's multi-decade Multikine journey extends with FDA request for new trial
CEL-SCI's multi-decade Multikine journey extends with FDA request for new trial
Fierce Biotech
Cel-Sci
Multikine
head and neck cancer
FDA
clinical trials
Flag link:
Psycheceutical starts a Phase I trial with topical ketamine
Psycheceutical starts a Phase I trial with topical ketamine
Clinical Trials Arena
Psycheceutical
PTSD
clinical trials
topical ketamine
NeuroDirect
Flag link:
Tryp to initiate psilocybin-assisted psychotherapy trial to treat IBS
Tryp to initiate psilocybin-assisted psychotherapy trial to treat IBS
Clinical Trials Arena
Tryp Therapeutics
clinical trials
IBS
psilocybin
Flag link:
Roche eyes alternate mode of administration for Ocrevus in MS
Roche eyes alternate mode of administration for Ocrevus in MS
Clinical Trials Arena
Roche
Ocrevus
clinical trials
MS
multiple sclerosis
Flag link:
Gut punch: First Wave's challenger to AbbVie fails phase 2 again
Gut punch: First Wave's challenger to AbbVie fails phase 2 again
Fierce Biotech
First Wave Biopharma
AbbVie
clinical trials
Creon
Flag link:
Incyte’s trial of ruxolitinib cream meets primary endpoint
Incyte’s trial of ruxolitinib cream meets primary endpoint
Clinical Trials Arena
Incyte
ruxolitinib
clinical trials
pediatric
atopic dermatitis
Flag link:
ADC Therapeutics Halts Enrollment of Zynlonta Trial After Seven Patient Deaths
ADC Therapeutics Halts Enrollment of Zynlonta Trial After Seven Patient Deaths
BioSpace
ADC Therapeutics
Zynlonta
clinical trials
patient deaths
diffuse large B-cell lymphoma
Flag link:
Retailers seek to shake up clinical trials business
Retailers seek to shake up clinical trials business
Axios
clinical trials
clinical trial recruitment
Kroger
Walgreens
Walmart
Flag link:
Iovance looks to advance its non-small cell lung cancer therapy
Iovance looks to advance its non-small cell lung cancer therapy
Clinical Trials Arena
Iovance Biotherapeutics
clinical trials
tumor-infiltrating lymphocyte therapy
non-small cell lung cancer
lifileucel
Flag link:
Janssen’s trial of plaque psoriasis therapy meets endpoints
Janssen’s trial of plaque psoriasis therapy meets endpoints
Clinical Trials Arena
Janssen
JNJ
clinical trials
JNJ-2113
plaque psoriasis
Flag link:
AstraZeneca stock slides as pivotal lung cancer readout on Daiichi-partnered ADC spooks investors
AstraZeneca stock slides as pivotal lung cancer readout on Daiichi-partnered ADC spooks investors
Fierce Biotech
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
clinical trials
non-small cell lung cancer
Flag link:
AstraZeneca’s liver cancer treatment shows ‘continued survival benefit’ in phase 3 trial
AstraZeneca’s liver cancer treatment shows ‘continued survival benefit’ in phase 3 trial
Biopharma Reporter
AstraZeneca
Imfinzi
liver cancer
clinical trials
Flag link:
Obesity: Six trials to watch over the next 12 months
Obesity: Six trials to watch over the next 12 months
Clinical Trials Arena
obesity
clinical trials
Novo Nordisk
Altimmune
Innovent Biologics
Pfizer
Shionogi
Tonix
semaglutide
oxytocin
permvidutide
mazdutide
danuglipron
Flag link:
Sellas celebrates positive Phase I results in lung cancer
Sellas celebrates positive Phase I results in lung cancer
Clinical Trials Arena
Sellas
clinical trials
immunotherapy
Opdivo
mesothelioma
lung cancer
Flag link:
Black Diamond’s lung cancer pivot delivers
Black Diamond’s lung cancer pivot delivers
EP Vantage
Black Diamond Therapeutics
clinical trials
BDTX-1535
lung cancer
Flag link:
10 clinical trials to watch in the second half of 2023
10 clinical trials to watch in the second half of 2023
BioPharma Dive
FDA
clinical trials
Sarepta Therapeutics
Bridge Bio
Sanofi
Merck KGaA
Pfizer
Novo Nordisk
Verve Therapeutics
Roche
Vertex Pharmaceuticals
JNJ
Bristol Myers Squibb
ATTR-CM
Elevidys
tolebrutinib
evobrutinib
danuglipron
tiragolumab
VX-548
lazertinib
Flag link:
Foghorn sinks plans for eye tumor drug after glimpsing phase 1 data
Foghorn sinks plans for eye tumor drug after glimpsing phase 1 data
Fierce Biotech
Foghorn Therapeutics
FHD-286
eye cancer
clinical trials
Flag link:

Pages